← 홈

Antibody

1,830개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-10 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,830개
AntibodystaleRochePhase 2

trastuzumab (Herceptin, doxorubicin, cyclophosphamide, paclitaxel, trastuzumab)

Breast Neoplasm · Breast Neoplasm

#BreastNeoplasm#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleStanford UniversityPhase 1

dupliumab (dupliumab)

Eosinophilic Disorder; Food Allergy · Eosinophilic Disorder

#EosinophilicDisorder#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleAstraZenecaPreclinical

durvalumab (Imfinzi, durvalumab + anlotinib)

Extensive-Stage Small-Cell Lung Cancer · Extensive-Stage Small-Cell Lung Cancer

#Extensive-StageSmall-CellLungCan#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAstraZenecaPhase 2

durvalumab (Imfinzi, durvalumab + chemotherapy treatment)

Platinum-resistant Recurrent Ovarian Cancer · Platinum-resistant Recurrent Ovarian Can

#Platinum-resistantRecurrentOvari#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAstraZenecaPhase 2

durvalumab (Imfinzi, durvalumab + tremelimumab + chemotherapy treatment)

Platinum-resistant Recurrent Ovarian Cancer · Platinum-resistant Recurrent Ovarian Can

#Platinum-resistantRecurrentOvari#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAstraZenecaPhase 2

durvalumab (Imfinzi, durvalumab + tremelimumab + paclitaxel treatment)

Platinum-resistant Recurrent Ovarian Cancer · Platinum-resistant Recurrent Ovarian Can

#Platinum-resistantRecurrentOvari#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAstraZenecaPhase 2

durvalumab (Imfinzi, durvalumab and vactosertib)

Stomach Neoplasm · Stomach Neoplasm

#StomachNeoplasm#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAstraZenecaPhase 2

cisplatin or carboplatin plus vinorelbine or pemetrexed (durvalumab plus platinum-based chemotherapy, durvalumab plus platinum-based chemotherapy (cisplatin or carboplatin plus vinorelbine or pemetrexed))

Non-small Cell Lung Cancer Stage III · Non-small Cell Lung Cancer Stage III

#Non-smallCellLungCancerStageIII#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleAstraZenecaPhase 2

durvalumab (Imfinzi, durvalumab, tremelimumab, bevacizumab)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleAstraZenecaPhase 2

durvalumab (Imfinzi, durvalumab, tremelimumab, paclitaxel)

Metastatic Gastric Cancer · Metastatic Gastric Cancer

#MetastaticGastricCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleUniversitätsklinikum Hamburg-Ep…Phase 3

ERD (elotuzumab/lenalidomide/dexamethasone, elotuzumab/lenalidomide/dexamethasone (ERD))

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleRocheApproved

eltrombopag combining rituximab (eltrombopag combining rituximab)

Primary Immune Thrombocytopenia (ITP) · Primary Immune Thrombocytopenia (ITP)

#PrimaryImmuneThrombocytopeniaITP#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleFondazione Policlinico Universi…Phase 2

encorafenib + cetuximab + FOLFIRI (encorafenib + cetuximab + FOLFIRI)

Colorectal Carcinoma; Colorectal Neoplasms · Colorectal Carcinoma

#ColorectalCarcinoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleGBG Forschungs GmbHPhase 3

epirubicin - cyclophosphamide / docetaxel + bevacizumab (epirubicin - cyclophosphamide / docetaxel + bevacizumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleGBG Forschungs GmbHPhase 3

trastuzumab (Herceptin, epirubicin - cyclophosphamide / docetaxel + trastuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleMemorial Sloan Kettering Cancer…Phase 2

erlotinib with cetuximab (erlotinib with cetuximab)

Lung Adenocarcinoma · Lung Adenocarcinoma

#LungAdenocarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleUniversity of GlasgowApproved

adalimumab (Humira, etanercept or adalimumab)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleGlaxoSmithKlinePhase 1

GSK3359609 (feladilimab, feladilimab (GSK3359609))

Neoplasms · Neoplasms

#Neoplasms#Antibody#Phase1#항체#면역항체+2
효능 0%임상시험 1상태 ACTIVE
AntibodystaleCTI BioPharmaPhase 3

fludarabine and rituximab (fludarabine and rituximab)

Non-Hodgkin's Lymphoma · Non-Hodgkin's Lymphoma

#Non-HodgkinsLymphoma#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleA.O. Ospedale Papa Giovanni XXI…Approved

fludarabine, cyclophosphamide, doxorubicin, rituximab (fludarabine, cyclophosphamide, doxorubicin, rituximab)

Post-transplant Lymphoproliferative Disease (PTLD); Non Burkitt · Post-transplant Lymphoproliferative Dise

#Post-transplantLymphoproliferati#Antibody#Approved#항체#면역항체+3
임상시험 1상태 ACTIVE

85 / 92 페이지

← 이전다음 →